Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pyrophosphate: a New Biomarker to Predict Arterial Calcification in Chronic Kidney Disease

NCT04950439 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nice as lead sponsor.

NCT NCT04950439
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04950439 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pyrophosphate: a New Biomarker to Predict Arterial Calcification in Chronic Kidney Disease
Lead sponsor
Centre Hospitalier Universitaire de Nice
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 14, 2022
Completion date
March 14, 2029
Enrollment
242 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney diseases